-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on WAVE Life Sciences, Lowers Price Target to $19

Benzinga·07/31/2026 20:43:21
Listen to the news
Citigroup analyst Samantha Semenkow maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $24 to $19.